We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Anastomosis System Attaches Multiple Blood Vessel Grafts

By HospiMedica staff writers
Posted on 05 Feb 2008
A new C-Port system allows surgeons to attach multiple blood vessel grafts using the same handle during a coronary artery bypass graft (CABG) procedure.

The C-Port xA X-Change Distal Anastomosis System C-Port system attaches the end of a bypass graft to a coronary artery downstream of an occlusion during coronary artery bypass graft (CABG) surgery. More...
The cartridge-based, reloadable C-Port system uses cartridges pre-loaded with miniature stainless steel staples to secure the bypass graft to the coronary artery. This allows the surgeon to complete multiple anastomoses using the same carbon dioxide (CO2) powered handle. Each device in the C-Port system product line is designed to enable automated, reliable, and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, the system creates compliant anastomoses that can expand and contract with blood flow. In addition, the anastomosis system, whether used during on- or off- pump surgery, offers surgeons access to a wide range of coronary arteries, particularly small coronary arteries, which, in the past, have been difficult or impossible to connect effectively. The C-Port xA X-Change Distal Anastomosis System is manufactured by Cardica (Redwood City, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA), and also bears the European Union CE mark of conformity.

"We are pleased to offer the cartridge-based C-Port xA X-CHANGE system in response to feedback from surgeons desiring a solution to address all of their bypass needs with a single handle, which is less expensive than using a new C-Port system for each anastomosis,” said Bernard A. Hausen, M.D., Ph.D., President and CEO of Cardica. "With the introduction of this product, we will continue to provide surgeons with the same mechanically-governed, reproducible anastomoses while enhancing the functionality and providing the ability to perform multiple anastomoses with one device.”


Related Links:
Cardica

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.